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ABSTRACT
Background: The relationship between chronic rhinosinusitis (CRS) and asthma has been known for a long
time. However, no large studies on the relationship between CRS and lower airway diseases have been re-
ported to date in Japan. Additionally, eosinophilic chronic rhinosinusitis (ECRS) in Japan is considered to be a
subgroup of CRS with nasal polyps (CRSwNP) characterized by eosinophil-dominant inflammation. However,
the diagnostic criteria of ECRS have not been established.
Methods: To investigate clinical and epidemiological features of patients with CRS from the aspect of their as-
sociations with lower airway diseases, 553 patients with CRS who visited one of six local university hospitals
were examined and interviewed. Local eosinophilic infiltration was evaluated pathologically by exmining NPs.
Results: The prevalences of olfactory dysfunction (OD) in the patients with nasal polyps (NPs) and those with-
out NPs were 57.0% and 13.7%, respectively (p < 0.0001). The prevalence of asthma in all patients was
23.1%. Furthermore, the prevalences of NPs and OD in the patients with asthma and those without asthma
were 81.0% and 50.1% (p < 0.0001) and 64.2% and 35.7% (p < 0.0001), respectively. 97.4% of the patients
with asthma had 15% mucosal eosinophils, and 87.9% of the patients without asthma had <15% mucosal
eosinophilis.
Conclusions: Similar to the relationship between nasal allergy and asthma, CRSwNP may be applicable to
the concept of “one airway, one disease”.
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INTRODUCTION
Chronic rhinosinusitis (CRS) is a common disease in
the otorhinolaryngology field in Japan. Previously,
CRS mostly consisted of chronic inflammation caused
by occlusion of the sinus ostia. Recently, however,
CRS with nasal polyps (NPs), in which distinct
eosinophilic infiltration can be observed, is rapidly in-
creasing. This latter disease is called eosinophilic
chronic rhinosinusitis (ECRS) in Japan.1,2 In Europe
and the United States, CRS characterized by eosino-
philic inflammation is called chronic hyperplastic
eosinophilic sinusitis (CHES),3 eosinophilic mucin
rhinosinusitis (EMRS)4 or chronic hyperplastic rhi-
nosinusitis with nasal polyposis (CHSNP).5 Each of
these conditions can be considered to be similar to
ECRS. Moreover, CRS has recently been divided into
two subgroups: chronic rhinosinusitis with nasal pol-
yps (CRSwNP) and chronic rhinosinusitis without na-
sal polyps (CRSsNP).6 Ishitoya et al.2 reported that
the concept of ECRS in Japan would be applicable for
CRSwNP in Europe and the United States.
The relationship between CRS and asthma has
been known for a long time. However, it is not fully
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understood. An epidemiological study reported that
93% of patients with EMRS were associated with
asthma and that 54% of these patients had aspirin-
intolerant asthma (AIA).4 Another study reported that
50% of CHSNP patients were associated with asthma
and that about 30-40% of these patients had AIA.5
Thus, ECRS is an eosinophilic inflammation that can
affect not only the nose and sinuses but also the bron-
chi, and can be considered to be an airway disease
consistent with the concept of “one airway, one dis-
ease”.
There have been epidemiological studies on upper
airway diseases in Japan from the aspect of asthma.7
However, from the aspect of CRS, no large studies on
the relationship between CRS and lower airway dis-
eases have been reported to date. In this study, we
conducted a large-scale survey among multiple insti-
tutions (six university hospitals). The study focused
on the clinical conditions of CRS and assessed the re-
lationships with lower airway diseases.
METHODS
PATIENTS
Patients with CRS who visited one of six local univer-
sity hospitals during 5 months from June 2005 to Oc-
tober 2005 were evaluated. Patients with CRS who
visited during that period were randomly selected,
and examined and interviewed for the items de-
scribed below. A total of 553 patients were included,
comprising 317 males, 229 females and 7 patients in
whom no gender was specified. The mean age was
51.5 ± 18.8 years (range: 3-92 years) and the mean du-
ration of CRS was 8.8 ± 13.2 years (range: 0.3-66
years).
The study was approved by the ethical committee
of each institution, and informed written consent to
the study protocol was obtained from all subjects.
CHRONIC RHINOSINUSITIS
The diagnostic criteria for CRS were defined by the
clinical symptoms (nasal obstruction, discolored dis-
charge (anteriorposterior nasal drip) or reduction
loss of smell) for more than 12 weeks, plain X-ray im-
aging and computed tomographic (CT) scanning.
The patients were asked about the disease duration,
whether they had an olfactory dysfunction (anosmia
hyposmia) and whether they had a history of surgery
for sinus diseases. The presence or absence of an ol-
factory dysfunction was determined based on the pa-
tient’s complaints. Plain X-ray examination, CT scan-
ning and endoscopy were performed on all patients.
The presence or absence of NPs was determined
visually using an endoscope. Surgery was reserved
for CRS patients with NPs or persistent cases after
conservative medication for a few months. Local
eosinophilic infiltration was evaluated pathologically
using NPs removed during surgery. The NPs were
stained with hematoxylin and eosin for detection of
tissue eosinophilia. The percentage of eosinophils in
each sample was calculated by dividing the number
of eosinophils by the total number of inflammatory
cells counted. We classified the degree of eosino-
philic infiltration into the following three groups by
comparing the percentages of eosinophils: mild
(<15%); moderate (15-30%) and severe (30%). Pa-
tients with moderate to severe degrees of eosino-
philic infiltration were considered to have the pres-
ence of eosinophilic infiltration. Our diagnostic crite-
rion for ECRS is mucosal eosinophilia (15%). The
procedures were carried out by experienced patholo-
gists without knowledge of the other clinical parame-
ters in each hospital.
LOWER AIRWAY DISEASES
Patients were asked if they had asthma that was still
under treatment and about the disease duration.
Among the patients with asthma, those who had ex-
perienced an attack induced by any non-steroidal anti-
inflammatory drug were considered to have aspirin-
intolerant asthma (AIA). Patients were also asked
whether their asthma had been improved after endo-
scopic sinus surgery (ESS). Patients whose medica-
tion dose or attack frequency had been reduced were
categorized into the improved group. The patients
were also asked whether they had any chronic ob-
structive pulmonary diseases (COPD).
STATISTICAL ANALYSIS
The prevalences of NPs and an olfactory dysfunction,
prevalences of lower airway diseases, prevalences of
NPs and an olfactory dysfunction in patients with
each lower airway disease, and surgery rates were
evaluated. The chi-square test was used for statistical
analyses of differences between groups and values of
p < 0.05 were considered to indicate statistical signifi-
cance. JMP software version 7.0.1 (SAS Institute Inc.,
Cary, NC, USA) was used for all analyses.
RESULTS
NASAL POLYPS AND OLFACTORY DYSFUNC-
TION IN ALL PATIENTS
Among all the 553 patients with CRS, 309 (55.9%) had
NPs and 227 (41.0%) did not have NPs, while no find-
ings were specified for 17 (3.1%). Furthermore,
among the 553 patients with CRS, 210 (38.0%) had an
olfactory dysfunction and 279 (50.5%) did not have an
olfactory dysfunction, while no findings were speci-
fied for 64 (11.5%) (Table 1).
The relationship between NPs and olfactory dys-
function was also evaluated. An olfactory dysfunction
was present in 176 of 309 (57.0%) patients with NPs,
compared with 31 of 227 (13.7%) patients without NPs
(Fig. 1). There was a significant difference in the
prevalences of olfactory dysfunction between the two
groups (p < 0.0001).
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Table　1　Nasal polyps and olfactory dysfunction in 553 patients with chronic rhinosinusitis
Present (%) Absent (%) Unknown (%)
Nasal polyps 309 (55.9) 227 (41.0) 17 (3.1)
Olfactory dysfunction 210 (38.0) 279 (50.5) 64 (11.5)
Table　2　Nasal polyps and olfactory dysfunction in 255 patients undergoing surgery
Present (%) Absent (%) Unknown (%)
Nasal polyps 172 (67.5) 76 (29.8) 7 (2.7)
Olfactory dysfunction 121 (47.5) 117 (45.9) 17 (6.6)
Fig.　1　Relationship between NPs and olfactory dysfunction. An olfactory dysfunction 
was reported in 176 of 309 (57.0%) patients with NPs (a), compared with 31 of 227 
(13.7%) patients without NPs (b).
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NASAL POLYPS AND OLFACTORY DYSFUNC-
TION IN PATIENTS UNDERGOING SURGERY
Among the 553 patients with CRS, ESS was per-
formed in 255 (46.1%). Among the 255 patients who
underwent ESS, 172 (67.5%) had NPs and 76 (29.8%)
did not have NPs, while no findings were specified for
7 (2.7%). Furthermore, among the 255 patients, 121
(47.5%) had an olfactory dysfunction and 117 (45.9%)
did not have an olfactory dysfunction, while no find-
ings were specified for 17 (6.6%) (Table 2).
PREVALENCES OF LOWER AIRWAY DISEASES
IN ALL PATIENTS
Among the 553 patients with CRS, 128 (23.1%) had
asthma (ATA in 99 [17.9%] and AIA in 29 [5.2%]) (Fig.
2). In addition, 15 patients had COPD (2.7%). The on-
set times of CRS and asthma were assessed. Among
the 128 patients who had both CRS and asthma, the
onset times of both diseases could be identified in 52
patients. Of these 52 patients, 15 (28.8%) developed
CRS first, 23 (44.2%) developed asthma first and 14
(26.9%) developed both diseases simultaneously.
There were no significant differences in the onset
times between the two diseases.
PREVALENCES OF NASAL POLYPS AND OL-
FACTORY DYSFUNCTION IN PATIENTS WITH
LOWER AIRWAY DISEASES
The prevalence of NPs was assessed for each lower
airway disease. Overall, 76 of 97 (78.4%) patients with
ATA, 26 of 29 (89.7%) patients with AIA and 7 of 13
(53.8%) patients with COPD had NPs. Among 400 pa-
tients without lower airway diseases, 200 (50.0%) had
NPs. As expected, about 90% of patients in the AIA
group and about 80% of patients in the ATA group
had NPs. The prevalences were significantly higher
in the ATA and AIA groups than in the group without
lower airway diseases (p < 0.0001 for each group)
(Fig. 3).
In the same way, the prevalence of patients with an
olfactory dysfunction was assessed for each lower air-
way disease. Overall, 54 of 93 (58.1%) patients with
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Fig.　2　Prevalences of lower airway diseases in 553 pa-
tients with chronic sinusitis. Among the 553 patients, 128 
(23.1%) patients were associated with asthma, comprising 
99 (17.9%) patients with ATA and 29 (5.2%) patients with 
AIA.
Unknown
(n = 5) 1%
No lower
airway disease
(n = 405) 73.2%
AIA
(n = 29) 5.2%
ATA
(n = 99) 17.9%
COPD
(n = 15) 2.7%
Fig.　3　Prevalences of NPs in patients with lower airway 
diseases. The prevalences of NPs are signifi cantly higher in 
the ATA and AIA groups than in the group without lower air-
way diseases (p < 0.0001 for each group). N.S, not statisti-
cally.
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Fig.　4　Prevalences of olfactory dysfunction in patients with 
lower airway diseases. The prevalences of olfactory dys-
function are signifi cantly higher in the ATA, AIA and COPD 
groups than in the group without lower airway diseases (p = 
0.0002, p < 0.0001 and p = 0.0311, respectively).
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Fig.　5　Eosinophilic infi ltration in patients with lower airway 
diseases. Among 210 patients who assessed for eosinophil-
ic infi ltration, 55 of 55 (100%) patients with ATA, 20 of 22 
(90.9%) patients with AIA and 16 of 133 (12.0%) patients 
without asthma had ≥15% eosinophils.
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ATA, 23 of 27 (85.2%) patients with AIA and 9 of 14
(64.3%) patients with COPD had an olfactory dysfunc-
tion. Among 359 patients without lower airway dis-
eases, 124 (34.5%) patients had an olfactory dysfunc-
tion. The prevalences of patients with an olfactory
dysfunction were significantly higher in the ATA and
AIA groups than in the group without lower airway
diseases (p = 0.0002 and p < 0.0001, respectively). In
addition, the prevalence was significantly higher in
the COPD group than in the group without lower air-
way diseases (p = 0.0311) (Fig. 4).
EOSINOPHILIC INFILTRATION
Among 255 patients who underwent ESS, 91 (35.7%)
had 15% eosinophils and 119 (46.7%) had <15%
eosinophils, while no findings were specified for 45
(17.6%). Among 210 patients who assessed for eosino-
philic infiltration, 55 of 55 (100%) patients with ATA,
20 of 22 (90.9%) patients with AIA and 16 of 133
(12.0%) patients without asthma had15% eosinophils
(Fig. 5).
In addition, among 198 patients in whom the pres-
ence or absence of olfactory dysfunction and eosino-
philic infiltration could be determined, the relation-
ship between olfactory dysfunction and eosinophilic
infiltration was assessed. Among the 198 patients, 99
(50.0%) had an olfactory dysfunction, 90 (45.5%) had
eosinophilic infiltration and 71 (35.9%) had both an ol-
factory dysfunction and eosinophilic infiltration (Ta-
ble 3).
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Table　3　Relationship between olfactory dysfunction and 
eosinophilic infi ltration in 198 patients in whom the presence 
or absence of an olfactory dysfunction and eosinophilic infi l-
tration could be confi rmed
Olfactory dysfunction
Eosinophilic infi ltration (≥15%)
 + -
 + 71 19
- 28 80
Fig.　6　Surgery rates in patients with lower airway diseas-
es. The rates of surgery are signifi cantly higher in the ATA 
and AIA groups than in the group without lower airway dis-
eases (p = 0.0029 and p < 0.0001, respectively). N.S, not 
statistically.
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SURGERY RATES IN PATIENTS WITH LOWER
AIRWAY DISEASES
Overall, 58 of 98 (59.2%) patients with ATA, 23 of 29
(79.3%) patients with AIA and 7 of 14 (50.0%) patients
with COPD underwent ESS. In contrast, among 405
patients without lower airway diseases, 167 (41.2%)
underwent ESS. The percentages of patients under-
going ESS were significantly higher in the ATA and
AIA groups than in the group without lower airway
diseases (p = 0.0029 and p < 0.0001, respectively)
(Fig. 6).
IMPROVEMENT IN ASTHMA AFTER SURGERY
Sixty-four patients with asthma in whom changes in
asthma after surgery could be identified were evalu-
ated. Among these 64 patients, 47 (73.4%) showed an
improvement and 17 (26.6%) did not show any im-
provement. No patients showed exacerbation of
asthma.
DISCUSSION
CRS is a common disease in the otorhinolaryngology
field. In recent years, with a decrease in CRS caused
by occlusion of the sinus ostia, which previously ac-
counted for the majority of sinusitis cases, sinusitis
showing distinct infiltration of activated eosinophils in
the sinus mucosa has been increasing. In 2006, CRS
has been divided into two subgroups: CRSwNP and
CRSsNP.6 ECRS in Japan is considered to be a sub-
group of CRSwNP in Europe and the United States.2
ECRS is characterized by adult onset, bilateral lesions
affecting the ethmoidal sinus rather than the maxil-
lary sinus, frequent olfactory disturbance and resis-
tance to treatment. Given the fact that systemic ster-
oid administration is effective, involvement of allergy
is suspected, although it remains unclear whether a
type I allergy is involved. Long-term low-dose macrol-
ide therapy is reported to be useful in postoperative
treatment for CRS8 and is widely used in clinical prac-
tice. However, in cases involving eosinophilic inflam-
mation, therapies with 14-membered ring macrolide
antibiotics are not effective and exacerbation is fre-
quently observed. In addition, it has been reported
that the exacerbation may be related to the lower air-
ways, and that it has a high complication rate for
asthma including AIA.4,5
Because awareness of the association between al-
lergic rhinitis as an upper airway disease and asthma
has been growing, international guidelines for aller-
gic rhinitis, designated Allergic Rhinitis and its Im-
pact on Asthma (ARIA), were proposed through a
joint project by the WHO and the International Asso-
ciation of Allergy and Clinical Immunology in 2001
and revised in 2008.9,10 In consideration of the rela-
tionship between CRS and asthma, we wondered
whether this relationship was consistent with the con-
cept of “one airway, one disease”, similar to the rela-
tionship between allergic rhinitis and asthma. The
prevalences of asthma in patients with CRS in previ-
ous reports were 23-50%.11-13 In this study, 23% of pa-
tients with CRS were associated with asthma. These
figures are higher than the asthma prevalence of 5%
in the general population.14 In addition, the preva-
lence of asthma in patients with CRS caused by occlu-
sion of the sinus ostia is considered to comprise only
a small percentage.15 From an epidemiological view-
point, it indicated that CRS have a relationship with
asthma. Moreover, the prevalence of NPs in patients
with asthma was significantly higher than that in pa-
tients without asthma, indicating that CRSwNP have
a close relationship with asthma.
Focusing on eosinophils, Jankowski et al.16 studied
nasal polyposis histologically and reported that 102
of 123 (82.9%) patients with nasal polyposis showed
>20% eosinophils and all 25 patients in a control group
for CRS showed <10% eosinophils. In Japan, histopa-
thological diagnostic criteria for ECRS have not been
established. When we defined 15% eosinophils as
the criterion for ECRS, almost all CRS patients with
asthma met our criterion. In addition, 91 (35.7%) of
255 patients who underwent ESS also met our crite-
rion. From histological viewpoint, it is suggested that
eosinophilic infiltration are highly correlated with
CRSwNP and asthma. Therefore, the concepts of
Yoshimura K et al.
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CRSwNP and CRSsNP need to be separated.
Olfactory dysfunction is one of only four signs and
symptoms included in the diagnostic criteria for CRS,
and it affects about 60% of CRS patients.17 Classically,
olfactory dysfunction in CRS was caused by mechani-
cal obstruction of the olfactory cleft by physical ob-
struction of the nasal airways, nasal polyposis, edema,
and secretions.18 However, Kern reported that CRS
patients had evidence of direct inflammation of the
neuroepithelium and that the degree of inflammatory
changes in the neuroepithelium was related to the se-
verity of olfactory dysfunction.19 In the present study,
the prevalences of NPs and olfactory dysfunction
were significantly higher in asthmatic groups than in
the group without asthma. It seems that olfactory dys-
function by CRS is caused by both conductive and
sensorineural process, and that the inflammatory re-
sponse and the effect to the respiratory epithelium
are more severe in CRS patients with asthma than in
the patients without asthma.
Interestingly, surgery for CRS improved the
asthma symptoms. There are several previous papers
reporting that ESS in patients with asthma resulted in
improvement of asthma symptoms, reduction in
medication doses and less frequent attacks.20-23 This
study was based on a questionnaire survey rather
than physical exam, however, 73.4% of patients
showed improvement in asthma after ESS, which
strongly suggests a relationship between the two dis-
eases in terms of treatment.
Based on the results of this study, the relationship
between ECRS and asthma may be applicable to the
concept of “one airway, one disease”.
CONFLICT OF INTEREST
No potential conflict of interest was disclosed.
REFERENCES
1. Haruna S, Otori N, Yanagi K, Moriyama H. [Eosinophilic
sinusitis]. Oto-Rhino-Laryngology Tokyo 2001;44:195-201
(in Japanese).
2. Ishitoya J, Sakuma Y, Tsukuda M. Eosinophilic chronic
rhinosinusitis in Japan. Allergol Int 2010;59:239-45.
3. Steinke JW, Borish L. The role of allergy in chronic rhi-
nosinusitis. Immunol Allergy Clin North Am 2004;24:45-
57.
4. Ferguson BJ. Eosinophilic mucin rhinosinusitis: a distinct
clinicopathological entity. Laryngoscope 2000;110:799-
813.
5. Hamilos DL. Chronic sinusitis. J Allergy Clin Immunol
2000;106:213-7.
6. Meltzer EO, Hamilos DL, Hardley JA et al. Rhinosinusitis:
developing guidance for clinical trials. J Allergy Clin Im-
munol 2006;118(5 Suppl):S17-61.
7. Matsuno O, Ono E, Takenaka R et al. Asthma and sinusi-
tis: association and implication. Int Arch Allergy Immunol
2008;147:52-8.
8. Moriyama H, Yanagi K, Ohtori N, Fukami M. Evaluation
of endoscopic sinus surgery for chronic sinusitis: Post-
operative erythromycin therapy. Rhinology 1995;33:166-
70.
9. Bousquet J, Van Cauwenberge P, Khaltaev N, Aria Work-
shop Group, World Health Organization. Allergic rhinitis
and its impact on asthma. J Allergy Clin Immunol 2001;
108:S147-334.
10. Bousquet J, Khaltaev N, Cruz AA et al. Allergic rhinitis
and its impact on asthma (ARIA) 2008 update (in collabo-
ration with the World Health Organization, GA(2)LEN
and allergen). Allergy 2008;63:8-160.
11. Seybt MW, McMains KC, Kountakis SE. The prevalence
and effect of asthma on adults with chronic rhinosinusitis.
Ear Nose Throat J 2007;86:409-11.
12. Annesi-Maesano I. Epidemiological evidence of the occur-
rence of rhinitis and sinusitis in asthmatics. Allergy 1999;
54(Suppl 57):7-13.
13. Slavin RG. Sinusitis in adults and its relation to allergic
rhinitis, asthma, and nasal polyp. J Allergy Clin Immunol
1988;82:950-6.
14. Grossman J. One airway, one disease. CHEST 1997;111:
11S-6.
15. Settipane GA. Epidemiology of nasal polyp. Allergy
Asthma Proc 1996;17:231-6.
16. Jankowski R, Bouchoua F, Coffinet L, Vignaud JM. Clini-
cal factors influencing the eosinophil infiltration of nasal
polyps. Rhinology 2002;40:173-8.
17. Rosenfeld RM, Andes D, Bhattacharyya N et al. Clinical
practice guidelines: Adult sinusitis. Otolaryngol Head Neck
Surg 2007;137(Suppl):S1-31.
18. Perry BF, Kountakis SE. Subjective improvement of olfac-
tory function after endoscopic sinus surgery for chronic
rhinosinusitis. Am J Otolaryngol 2003;24:366-9.
19. Kern RC. Chronic sinusitis and anosmia: pathologic
changes in the olfactory mucosa. Laryngoscope 2000;110:
1071-7.
20. Dhong HJ, Jung YS, Chung SK, Choi DC. Effect of endo-
scopic sinus surgery on asthmatic patients with chronic
rhinosinusitis. Otolaryngol Head Neck Surg 2001;124:99-
104.
21. Palmer JN, Conley DB, Dong RG, Ditto AM, Yarnold PR,
Kern RC. Efficacy of endoscopic sinus surgery in the
management of patients with asthma and chronic sinusi-
tis. Am J Rhinol 2001;15:49-53.
22. Batra PS, Kern RC, Tripathi A et al. Outcome analysis of
endoscopic sinus surgery in patients with nasal polyps
and asthma. Laryngoscope 2003;113:1703-6.
23. Nishioka GJ, Cook PR, Davis WE, McKinsey JP. Func-
tional endoscopic sinus surgery in patients with chronic
sinusitis and asthma. Otolaryngol Head Neck Surg 1994;
110:494-500.
